Colorado Blood Cancer Institute Medical Group

The Colorado Blood Cancer Institute Medical Group consists of the Physicians, Nurse Practitioners, and Physician Assistants providing patient care at the Colorado Blood Cancer Institute. CBCI is the regions leading center for blood cancer treatment and transplant, both in terms of volume and quality. CBCI is on the cutting edge of the latest research in coordination with the Sarah Cannon Research Network. CBCI leads the region in CAR T-Cell therapy and is becoming a nationally recognized center for autoimmune disease transplant

Leukemia,lymphoma,multiple myeloma,amyloidosis,autoimmune diseases,hodgkin's lymphoma,myelodysplastic syndrome (mds),waldenstrom's macroglubulinemia,chronic myeloid leukemia (cml),aplastic anemia,acute lymphocytic leukemia (all),acute myeloid leukemia (aml),non-hodgkin's lymphoma (nhl),multiple sclerosis,stiff person syndrome,t-cell lymphoma,mantle cell lymphoma (mcl),follicular lymphoma,diffuse large b-cell lymphoma,chronic lymphocytic leukemia (cll),small lymphocyctic lymphoma (sll),burkitt's lymphoma,hairy cell lymphoma,stem cell transplant,bone marrow transplant (bmt),car t-cell therapy,and scleroderma

Colorado blood cancer institute medical group operates in the Hospitals and health care industry.

Colorado blood cancer institute medical group's revenue is 11m - 100m

Colorado blood cancer institute medical group has 51 - 200 employees.